Related Experiment Videos
Intracellular signalling and cancer: complex pathways lead to multiple targets
1Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
European Journal of Cancer (Oxford, England : 1990)
|January 22, 2005
Summary
Cancer arises from disruptions in normal cell growth and death pathways. Understanding these complex intracellular alterations is crucial for identifying new therapeutic targets in various tumor types.
Area of Science:
- Cell biology
- Molecular oncology
- Cancer research
Background:
- Normal tissue homeostasis relies on tightly regulated cellular processes like proliferation, differentiation, and apoptosis.
- Complex intracellular signaling pathways with checkpoints maintain this balance, preventing uncontrolled growth.
- Aberrations in these pathways are fundamental to the development of malignancy.
Purpose of the Study:
- To investigate the intricate intracellular pathways governing normal cell function.
- To understand how disruptions in these pathways lead to cancer development.
- To identify and functionally assess novel therapeutic targets across diverse tumor types.
Main Methods:
- Dissection and functional assessment of key intracellular pathways.
- Analysis of tumor-specific and inter-individual variations in pathway alterations.
- Identification of potential therapeutic targets based on pathway dysregulation.
Main Results:
- Identified critical intracellular pathway aberrations driving malignancy.
- Characterized the tumor-specific and inter-individual heterogeneity of these alterations.
- Established a framework for assessing the therapeutic potential of targeting these pathways.
Conclusions:
- Aberrant intracellular signaling is central to cancer.
- The heterogeneity of these alterations necessitates individualized therapeutic strategies.
- Targeting dysregulated pathways offers promising avenues for cancer treatment.